2-Sulfamoylbenzoic acid derivatives of general formula (I):
1
which have both an antagonistic effect on the leukotriene D
4
receptor and an antagonistic effect on the thromboxane A
2
receptor and salts thereof, pharmaceuticals, anti-allergic agents and leukotriene.thromboxane A
2
antagonistic agents containing them as an active ingredient.
The present invention relates to a cinnamoyl compound represented by the formula (I):
本发明涉及一种由式(I)表示的肉桂酰化合物。
SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID RECEPTOR (KOR) AGONISTS
申请人:Dr. Reddy's Laboratories Ltd.
公开号:US20150031685A1
公开(公告)日:2015-01-29
The present invention relates to a series of substituted compounds having the general formula (I), including their stereoisomers and/or their pharmaceutically acceptable salts, wherein R
1
, R
2
, R
3
, R
4
, R
5
, and R
6
are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (κ) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.
A composition for inhibiting the extracellular matrix gene transcription comprising a cinnamoyl compound represented by the formula (I):
and an inert carrier, or the like.
2-Sulfamoylbenzoic acid derivatives of general formula (I):
which have both an antagonistic effect on the leukotriene D4 receptor and an antagonistic effect on the thromboxane A2 receptor and salts thereof, pharmaceuticals, anti-allergic agents and leukotriene·thromboxane A2 antagonistic agents containing them as an active ingredient.